High expression of epithelial cellular adhesion molecule in peritoneal metastasis of gastric cancer

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Targeted oncology

• Publication date

  2013-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11523-012-0239-4PMID 23161021
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A preliminary study of single intraperitoneal administration of paclitaxel followed by sequential systemic chemotherapy with S-1 plus paclitaxel for advanced gastric cancer with peritoneal metastasis.

  2012cited by this paper
• Safety of intraperitoneal administration of paclitaxel after gastrectomy with en‐bloc D2 Lymph node dissection

  2012cited by this paper
• Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research

  2011cited by this paper
• Catumaxomab

  2010cited by this paper
• The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

  2010cited by this paper
• RETRACTED ARTICLE: EpCAM: A Potential Antimetastatic Target for Gastric Cancer

  2010influential reference
• EpCAM is overexpressed in gastric cancer and its downregulation suppresses proliferation of gastric cancer

  2009cited by this paper
• Prowling wolves in sheep's clothing: the search for tumor stem cells

  2008cited by this paper
• S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

  2008cited by this paper
• Molecular Cancer BioMed Central

  2008cited by this paper
• EpCAM (CD326) finding its role in cancer

  2007cited by this paper
• Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers

  2006cited by this paper
• Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

  2006cited by this paper
• Adjuvant Therapy with Edrecolomab versus Observation in Stage II Colon Cancer: A Multicenter Randomized Phase III Study*

  2005cited by this paper
• Evaluation of a Panel of Molecular Markers for the Diagnosis of Malignant Serous Effusions

  2005cited by this paper
• The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation

  2004cited by this paper
• EpCAM Is Overexpressed in Breast Cancer and Is a Potential Target for Breast Cancer Gene Therapy

  2004cited by this paper
• Overexpression of Epithelial Cell Adhesion Molecule Antigen in Gallbladder Carcinoma Is an Independent Marker for Poor Survival

  2004cited by this paper
• Expression of Ep-CAM shifts the state of cadherin-mediated adhesions from strong to weak.

  2003cited by this paper
• Prognostic significance of Ep‐CAM AND Her‐2/neu overexpression in invasive breast cancer

  2002cited by this paper
• Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database.

  2001cited by this paper
• Clinical Pathway for the Management of Resectable Gastric Cancer with Peritoneal Seeding: Best Palliation with a Ray of Hope for Cure

  2000cited by this paper
• Peritoneal carcinomatosis from non‐gynecologic malignancies

  2000cited by this paper
• Utility of BER‐EP4 in the diagnosis of adenocarcinoma in effusions: An immunocytochemical study of 232 cases

  1993cited by this paper
• Immunocytochemical Staining of Serous Effusions With the Monoclonal Antibody Ber‐Ep4

  1992cited by this paper

• Molecular mechanisms of metastatic peritoneal dissemination in gastric adenocarcinoma

  2025cites this paper
• Molecular and Genetic Markers of Peritoneal Metastasis.

  2025cites this paper
• Mutational and transcriptional profile predicts the prognosis of stage IV gastric cancer - Prognostic factors for metastatic gastric cancer.

  2024cites this paper
• Rat tight junction proteins are disrupted after subchronic exposure to okadaic acid

  2023cites this paper
• The Role of Cancer Stem Cells in Drug Resistance in Gastroesophageal Junction Adenocarcinoma

  2021cites this paper
• Sensitive electrochemical aptasensor for detecting EpCAM with silica nanoparticles and quantum dots for signal amplification

  2020cites this paper
• Cancer stem cells: A review from origin to therapeutic implications

  2020cites this paper
• Current progress in the clinical use of circulating tumor cells as prognostic biomarkers

  2019cites this paper
• The Pattern of Signatures in Gastric Cancer Prognosis

  2018cites this paper
• Upregulation of LncRNA BCYRN1 promotes tumor progression and enhances EpCAM expression in gastric carcinoma

  2017cites this paper
• Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFβ1-independent manner

  2017cites this paper
• Clinical significance of circulating tumor cells in gastric cancer patients

  2017cites this paper
• Isolation, identification, and characterization of cancer stem cells: A review

  2017cites this paper
• The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells

  2016cites this paper
• Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options

  2016cites this paper
• Expression of epithelial cellular adhesion molecule in gastric cancer: A meta-analysis

  2016cites this paper
• Chapter 5 Adhesion molecules in peritoneal metastases of colorectal cancer : Function , prognostic relevance and therapeutic options

  2016cites this paper
• Capture of Tumor Cells on Anti-EpCAM-Functionalized Poly(acrylic acid)-Coated Surfaces.

  2016cites this paper
• Whole-exome sequencing to identify somatic mutations in peritoneal metastatic gastric adenocarcinoma: A preliminary study

  2016cites this paper
• Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study

  2016cites this paper
• Gastric cancer stem cells: evidence, potential markers, and clinical implications

  2016cites this paper
• UvA-DARE ( Digital Academic Repository ) HIPEC treatment of peritoneal carcinomatosis in colorectal and gastric cancer

  2015cites this paper
• UvA-DARE ( Digital Academic Repository ) HIPEC treatment of peritoneal carcinomatosis in colorectal and gastric cancer

  2015cites this paper
• Prognostic Role of a Multimarker Analysis of Circulating Tumor Cells in Advanced Gastric and Gastroesophageal Adenocarcinomas

  2015cites this paper
• Treatment strategies for gastric cancer patients with peritoneal metastasis

  2014cites this paper